Illumina Inc. (ILMN) is in the Health Care Industry

• Sort by
• View by Content Type
• View Related Content by Tag

• Best and Worst Performing Stocks of the Current Bear Market

  Hickey and Walters Bespoke submit: Since the current bear market began back on October 9th, 2007, the Russell 1,000 is down about 18%.  Of the stocks in the index, 8.5% are down more than 50%, while 25% are actually up since then.  Below we highlight the 25 best...

  External links 2008-08-25

  Tags: US Market, Financial, Arch Coal Inc., American International Group Inc., Alpha Natural Resources Inc., APP Pharmaceuticals Inc., Bucyrus International Inc., Boyd Gaming Corp., Avis Budget Group Inc., CF Industries Holdings Inc., CIT Group, Cleveland-Cliffs Inc., Continental Resources Inc., Encore Acquisition Co., E*Trade Financial Corp., Flowserve Corp., Fannie Mae, Freddie Mac, First Solar Inc., General Motors Corp., Hess Corp., Petrohawk Energy Corp., Helmerich & Payne Inc., Illumina Inc., Kansas City Southern, Lehman Brothers Holdings Inc., Las Vegas Sands Corp., MasterCard Inc., MBIA Inc., Massey Energy Co., Mosaic Co., MGIC Investment Corp., National City Corp., Office Depot Inc., Oshkosh Truck Corp., Perrigo Co., Rite Aid Corp., Regions Financial Corp., iStar Financial Inc., SLM Corp., SanDisk Corp., Sohu.com, Southwestern Energy Co., Tenet Healthcare Corp., Terra Industries Inc., Tesoro Corp., Wachovia Corp., Whiting Petroleum Corp., Walter Industries Inc., Washington Mutual Inc.

• Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare

  Trader Mark submits: One area you can see I've been transitioning into is healthcare. I still don't buy the "technology is a safe haven" thesis, but I have to respect that's where money flow is going. Healthcare I can feel a bit more comfortable with because it's a...

  External links 2008-08-15

  Tags: ETF, Affymetrix, Biogen Idec Inc., Genentech Inc., Gilead Sciences Inc., Illumina Inc.

• Illumina Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions Our first question comes from the line of Ross Muken. Please proceed. Ross Muken - Deutsche Bank Good afternoon gentlemen. Jay Flatley Hi, Ross. Christian Henry Hi, Ross. Ross Muken - Deutsche Bank Congratulations, wonderful quarter. There was a bit of concern...

  Earnings calls 2008-07-22

  Tags: Illumina Inc.

• Illumina Inc. Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions Our first question comes from the line of Ross Muken from Deutsche Bank. Please proceed. Ross Muken - Deutsche Bank Good afternoon, gentlemen. It’s a long day. So, as we look at the quarter I think obviously the growth is pretty astounding that you are...

  Earnings calls 2008-04-22

  Tags: Illumina Inc.

• Illumina Q4 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions Our first question comes from the line of Ross Mukin at Deutsche Bank. Go ahead. Ross Mukin – Deutsche Bank Securities On the consumable pull through for the Bead stations can you talk about obviously now the HD product is coming to...

  Earnings calls 2008-02-04

  Tags: Illumina Inc.

Additional Resources

• Geospiza Extends Data Analysis Capabilities for Next Generation DNA Sequencing with New FinchLab Release

  Market Leading Software Platform for Genetic Analysis Increases Support for AB SOLiD, Illumina GA and Roche 454 SEATTLE -- Geospiza, Inc., the market leading developer of genetic analysis software, today announced its most recent FinchLab[TM] software release, including significant analysis enhancements for Next Generation Sequencing. FinchLab...

  Articles 2008-10-08

• CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology

  AARHUS, Denmark -- Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in leading next generation sequencing data analysis by becoming...

  Articles 2008-10-02

• Seven Summits Research Releases Comments on GOOG, COP, JOSB, ILMN, and VMC

  CHICAGO, Sept. 18 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: http://www.go7now.com/nb/0918Y (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven...

  Articles 2008-09-18

• Illumina Inc

  Illumina Inc. announced the appointment of Mostafa Ronaghi as senior vice president and chief technology officer. Ronaghi will be responsible for leading the technology development effort at Illumina. --Compiled by Kevin Black CONTACT POINT Please e-mail new hire and career move announcements, including photographs...

  Articles 2008-08-18

• Lab instrument sales index withstands economic woes

  In the second quarter of 2008, revenues for IBO's Laboratory Sales Index grew 13.7% to $4,624 million, compared to growth of 13.3% in second quarter of 2007. Operating profit climbed 20.4% to $747 million, and operating margin climbed 90 basis points to 16.2% of sales. While several companies, such as...

  Articles 2008-08-15

• Illumina

  Illumina introduced the HumanHT-12 BeadChip, a 12-sample product for whole genome expression and expression-based quantitative trait loci studies. It is priced at $75 for a total cost of $100 per sample including labeling reagents...

  Articles 2008-08-15

• Illumina

  Illumina launched the iScan System, its next-generation scanner, which improves sample throughput sixfold, in the second quarter...

  Articles 2008-08-15

• Dietary supplement maker BioPharma Scientific Inc. has subleased 9,000 square feet of warehouse space at 7776 Trade St. in Sorrento Valley from Illumina Inc

  Dietary supplement maker BioPharma Scientific Inc. has subleased 9,000 square feet of warehouse space at 7776 Trade St. in Sorrento Valley from Illumina Inc. The three-year lease is valued at $252,584. Andy Irwin of CB Richard Ellis represented the lessee. Steve Rosetta and Sean Williams of Cushman & Wakefield represented...

  Articles 2008-08-11

• Illumina makes $300m stock move: genetic analysis company Illumina Inc. said it will offer 3.5 million shares of its stock to the public for $87.50 a share

  Illumina Makes $300M Stock Move: Genetic analysis company Illumina Inc. said it will offer 3.5 million shares of its stock to the public for $87.50 a share. Illumina estimated that the offering would provide the company with $300 million. The company's prospectus says it will use the cash...

  Articles 2008-08-11

• BellwetherReport.com Analyst Report on ACOR, CTRN, ARMH and ILMN

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...

  Articles 2008-08-07

• Illumina Appoints Mostafa Ronaghi as Senior Vice President and Chief Technology Officer

  SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of Dr. Mostafa Ronaghi as Senior Vice President and Chief Technology Officer. As reported during Illumina's July 22, 2008 second quarter earnings release, Dr. Ronaghi joined Illumina following the Company's recent acquisition of Avantome, Inc., which closed on August 1,...

  Articles 2008-08-04

• Illumina Announces 3.5 Million Share Public Offering

  SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it has filed a preliminary prospectus supplement to a shelf registration statement with the Securities and Exchange Commission relating to a proposed public offering of 3,500,000 shares of its common stock. The underwriter will be granted the right to purchase up...

  Articles 2008-08-04

• Illumina to Present at the Leerink Swann Life Science Tools Roundtable Conference

  SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) announced today that the Company will webcast its presentation at the Leerink Swann Life Science Tools Roundtable Conference on Thursday, August 7, 2008 in New York, NY. The live webcast is scheduled to begin at 10:40am ET and will feature a discussion with Jay...

  Articles 2008-07-31

• The bottom line; data from recent industry financial reports. Dollar amounts in millions

  The Bottom LineData from recent industry financial reports. Dollar amounts inmillions.Company Period Ended Sales ...

  Articles 2008-07-31

• Illumina invests in new sequencing technology

  San Diego, CA 7/22/08--Illumina has acquired Avantome, the developer of a long read-length sequencing technology, for $25 million in cash and contingent payments of up to $35 million. Avantome's principal founders Mostafa Ronaghi and Helmy Eltoukhy will join Illumina. Dr. Ronaghi will serve as senior vice president and chief technical...

  Articles 2008-07-31